VERTOS V.
Trial name or title | VERTOS V |
Methods | Randomised controlled trial, participant blinded |
Participants | Planned sample size = 94 Inclusion criteria
Exclusion criteria
|
Interventions |
|
Outcomes | Duration of follow‐up to 12 months Primary outcome
Secondary outcomes
|
Starting date | May 2013 |
Contact information | Dr Dennis Carli |
Notes | Trial registration: NCT01963039 Primary sponsor: St. Elisabeth Hospital, Tilburg, the Netherlands Study completed June 2015 (as reported at clinicaltrials.gov in September 2016); no study results posted. Status changed 12 January 2017: study now 'enrolling by invitation', with a new estimated completion date of July 2018 |
MRI: magnetic resonance imaging ODI: Oswestry disability index OVCF: osteoporotic vertebral compression fracture RMDQ: Roland‐Morris Disability Questionnaire QUALEFFO: Quality of Life Questionnaire of the European Foundation for Osteoporosis VAS: visual analogue scale VCF: vertebral compression fracture